(Total Views: 543)
Posted On: 02/29/2020 3:39:21 PM
Post# of 149238
CytoDyn made the list!
Not sure if this was already posted (came out yesterday), but nice to see leronlimab actually make it on one of these lists
https://www.clinicaltrialsarena.com/analysis/...cov-drugs/
Not sure if this was already posted (came out yesterday), but nice to see leronlimab actually make it on one of these lists
https://www.clinicaltrialsarena.com/analysis/...cov-drugs/
Quote:
CytoDyn-leronlimab
CytoDyn is examining leronlimab (PRO 140), a CCR5 antagonist, as a potential coronavirus drug.
The drug is already being investigated in phase two clinical trials as a treatment for HIV and has been awarded fast-track approval status by the United States Food and Drug Administration.
(2)
(0)Scroll down for more posts ▼
